Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shinji Oki

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Neurochemistry International|December 4, 2018
Eomes-expressing T-helper cells as potential target of therapy in chronic neuroinflammationShinji Oki
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|May 24, 2016
Pathological mechanism of secondary-progressive multiples sclerosis and its animal modelShinji Oki
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|September 2, 2009
[Identification of a possible therapeutic target through pathogenic T cell analysis of multiple sclerosis]Shinji Oki, Takashi Yamamura
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 19, 2014
[Experimental animal model of multiple sclerosis--transverse investigation of MS pathogenesis for therapeutic intervention]Shinji Oki, Takashi Yamamura
Allergology International : Official Journal of the Japanese Society of Allergology|January 30, 2007
Invariant natural killer T (iNKT) cells in asthma: a novel insight into the pathogenesis of asthma and the therapeutic implication of glycolipid ligands for allergic diseasesShinji Oki, Sachiko Miyake
Plos One|February 26, 2013
Nuclear receptor NR4A2 orchestrates Th17 cell-mediated autoimmune inflammation via IL-21 signallingBen J E Raveney, Shinji Oki, Takashi Yamamura
The Journal of Clinical Investigation|June 3, 2004
The clinical implication and molecular mechanism of preferential IL-4 production by modified glycolipid-stimulated NKT cellsShinji Oki, Asako Chiba, Takashi Yamamura, et al.
International Immunology|November 18, 2005
Preferential T(h)2 polarization by OCH is supported by incompetent NKT cell induction of CD40L and following production of inflammatory cytokines by bystander cells in vivoShinji Oki, Chiharu Tomi, Takashi Yamamura, et al.
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|March 3, 2009
Retinoid signals and Th17-mediated pathologyChristian Klemann, Benjamin Je Raveney, Shinji Oki, et al.
Arthritis and Rheumatism|June 4, 2005
The involvement of V(alpha)14 natural killer T cells in the pathogenesis of arthritis in murine modelsAsako Chiba, Shinjiro Kaieda, Shinji Oki, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Neurochemistry International|December 4, 2018
Eomes-expressing T-helper cells as potential target of therapy in chronic neuroinflammationShinji Oki
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|May 24, 2016
Pathological mechanism of secondary-progressive multiples sclerosis and its animal modelShinji Oki
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|September 2, 2009
[Identification of a possible therapeutic target through pathogenic T cell analysis of multiple sclerosis]Shinji Oki, Takashi Yamamura
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 19, 2014
[Experimental animal model of multiple sclerosis--transverse investigation of MS pathogenesis for therapeutic intervention]Shinji Oki, Takashi Yamamura
Allergology International : Official Journal of the Japanese Society of Allergology|January 30, 2007
Invariant natural killer T (iNKT) cells in asthma: a novel insight into the pathogenesis of asthma and the therapeutic implication of glycolipid ligands for allergic diseasesShinji Oki, Sachiko Miyake
Plos One|February 26, 2013
Nuclear receptor NR4A2 orchestrates Th17 cell-mediated autoimmune inflammation via IL-21 signallingBen J E Raveney, Shinji Oki, Takashi Yamamura
The Journal of Clinical Investigation|June 3, 2004
The clinical implication and molecular mechanism of preferential IL-4 production by modified glycolipid-stimulated NKT cellsShinji Oki, Asako Chiba, Takashi Yamamura, et al.
International Immunology|November 18, 2005
Preferential T(h)2 polarization by OCH is supported by incompetent NKT cell induction of CD40L and following production of inflammatory cytokines by bystander cells in vivoShinji Oki, Chiharu Tomi, Takashi Yamamura, et al.
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|March 3, 2009
Retinoid signals and Th17-mediated pathologyChristian Klemann, Benjamin Je Raveney, Shinji Oki, et al.
Arthritis and Rheumatism|June 4, 2005
The involvement of V(alpha)14 natural killer T cells in the pathogenesis of arthritis in murine modelsAsako Chiba, Shinjiro Kaieda, Shinji Oki, et al.
Pageof 4